U.S. Markets closed

Here's Why Longeveron Is Surging Today

·1 min read
Here's Why Longeveron Is Surging Today
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

An orphan drug designation for the treatment of a rare heart condition is pushing the biotech stock higher.